Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SYNH

Syneos Health (SYNH) Stock Price, News & Analysis

Syneos Health logo

About Syneos Health Stock (NASDAQ:SYNH)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$42.97
$42.99
50-Day Range
$42.48
$42.98
52-Week Range
$22.89
$52.23
Volume
7.39 million shs
Average Volume
1.92 million shs
Market Capitalization
$4.46 billion
P/E Ratio
62.29
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Syneos Health, Inc., operates as an integrated biopharmaceutical solutions company. The company operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in Phase I to IV of clinical development. This segment offers individual services, including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication; and consulting services. Its customers include companies in the biopharmaceutical, biotechnology, and medical device industries. It operates in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company has a strategic partnership with uMotif Limited to deliver patient-centric eClinical platform. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina. As of September 28, 2023, Syneos Health, Inc. was taken private.

Remove Ads
Receive SYNH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Syneos Health and its competitors with MarketBeat's FREE daily newsletter.

SYNH Stock News Headlines

Trump Treasure April 19
Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…
Hayward Holdings, Inc. (HAYW)
See More Headlines

SYNH Stock Analysis - Frequently Asked Questions

Syneos Health, Inc. (NASDAQ:SYNH) announced its quarterly earnings data on Wednesday, November, 3rd. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.17 by $0.05. The firm's revenue was up 22.7% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Syneos Health investors own include AT&T (T), NVIDIA (NVDA), Bristol-Myers Squibb (BMY), PayPal (PYPL), Applied Materials (AMAT), Advanced Micro Devices (AMD) and Intel (INTC).

Company Calendar

Last Earnings
11/03/2021
Today
4/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
NASDAQ:SYNH
Employees
28,768
Year Founded
N/A

Profitability

Trailing P/E Ratio
62.29
Forward P/E Ratio
15.41
P/E Growth
N/A
Net Income
$266.50 million
Pretax Margin
1.53%

Debt

Sales & Book Value

Annual Sales
$5.39 billion
Cash Flow
$6.72 per share
Price / Cash Flow
6.40
Book Value
$33.96 per share
Price / Book
1.27

Miscellaneous

Free Float
103,366,000
Market Cap
$4.46 billion
Optionable
Optionable
Beta
1.58

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:SYNH) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners